Business
AstraZeneca COVID-19 vaccine trial volunteer ‘had neurological symptoms’ – Sydney Morning Herald
A woman in the trial in the UK had symptoms consistent with a rare but serious spinal inflammatory disorder, according to a report.
AstraZeneca said a woman in the United Kingdom had symptoms consistent with a rare but serious spinal inflammatory disorder, which led to the British drugmaker’s decision to stop its clinical study of the new coronavirus vaccine, Stat News has reported.
The participant was recovering and will likely be discharged from the hospital within a day, according to Stat News, which said on Wednesday the new disclosures by Astra Chief Executive Pascal Soriot were shared by three of the investors partici…
-
Noosa News17 hours agoBrisbane nation’s third-youngest capital; Leaders condemn anti-immigration rally
-
Noosa News7 hours agoPill checking to resume in Queensland months after government axed funding
-
General20 hours agoAs Iran-Australia relations plunge to a new low, Tehran faces another diplomatic setback
-
Business9 hours agoWhy Lynas, Mesoblast, PEXA, and Sayona Mining shares are tumbling today